A case report: clinically benign anti-Cs(a).
Previous reports on the clinical significance of anti- Csa(Cost-Stirling) have presented conflicting data. We report our findings, over an 8-month period, of a patient whose serum contained anti-Csa and anti-Fya. Nineteen donor units of ABO and Rh-matched, Fya-negative red cells, which were crossmatch incompatible, were transfused with no clinical, serological, or biochemical evidence of a hemolytic transfusion reaction.
Sererat
T
T
American Red Cross Blood Services, Northwest Ohio Region, 2275 Collingwood Blvd., Toledo, OH 43620, USA.
Alexander
J
J
Beatty
J
J